H.R. 3347 · 114th Congress
Byron Nash Renal Medullary Carcinoma Awareness Act of 2015
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
GreenSponsor5 cosponsors · 3 D, 2 R
5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.
What it does: CRS summary · Introduced in House · Jul 29, 2015
Byron Nash Renal Medullary Carcinoma Awareness Act of 2015
This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Byron Nash Renal Medullary Carcinoma Awareness Act of 2015
Latest action (Jul 31, 2015): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 29, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.